Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Euronext Paris  >  Imerys    NK   FR0000120859

IMERYS

(NK)
  Report  
Real-time Quote. Real-time Tradegate - 11/18 07:34:21 am
37.42 EUR   -1.16%
11/05IMERYS : further expands in calcium carbonates in Brazil
AQ
10/28IMERYS : 3rd quarter earnings
CO
10/28IMERYS : Slide show Q3 results
CO
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsPress ReleasesOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations

Imerys : FDA alerts consumers of J&J baby powder recall, says it stands by tests

share with twitter share with LinkedIn share with facebook
share via e-mail
0
10/18/2019 | 07:18pm EST

NEW YORK (Reuters) - The U.S. Food & Drug Administration said on Friday that it found that a sample from one lot of Johnson & Johnson's baby powder contained chrysotile fibers, a type of asbestos, confirming test results the company disclosed earlier on Friday.

In an emailed statement, the FDA said that it stands by the quality of its testing and results, and that it is not aware of any adverse events relating to exposure to the lot of affected product, but advised consumers to stop using powder from that batch.

(Reporting by Caroline Humer; Editing by Bill Berkrot)

Stocks mentioned in the article
ChangeLast1st jan.
IMERYS -1.22% 37.42 Real-time Quote.-9.81%
JOHNSON & JOHNSON 3.04% 134.94 Delayed Quote.4.56%
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on IMERYS
11/05IMERYS : further expands in calcium carbonates in Brazil
AQ
10/28IMERYS : 3rd quarter earnings
CO
10/28IMERYS : Slide show Q3 results
CO
10/23IMERYS : PR Press release by the Board of Directors
AQ
10/22EUROPE : European stocks subdued by mixed corporate earnings and Brexit
RE
10/22IMERYS : French specialty minerals group Imerys cuts outlook, announces CEO resi..
RE
10/18IMERYS : FDA alerts consumers of J&J baby powder recall, says it stands by tests
RE
10/18J&J recalls 33,000 bottles of baby powder as FDA finds asbestos in sample
RE
09/26MARTINA MERZ : Thyssenkrupp's Merz drops SAF Holland chairwoman role
RE
09/25GUIDO KERKHOFF : Thyssenkrupp faces more turmoil as CEO Kerkhoff set to leave
RE
More news
Financials (EUR)
Sales 2019 4 470 M
EBIT 2019 442 M
Net income 2019 254 M
Debt 2019 1 388 M
Yield 2019 5,80%
P/E ratio 2019 12,7x
P/E ratio 2020 10,7x
EV / Sales2019 0,98x
EV / Sales2020 0,96x
Capitalization 3 000 M
Chart IMERYS
Duration : Period :
Imerys Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends IMERYS
Short TermMid-TermLong Term
TrendsBullishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 7
Average target price 38,76  €
Last Close Price 37,86  €
Spread / Highest target 41,6%
Spread / Average Target 2,37%
Spread / Lowest Target -18,1%
EPS Revisions
Managers
NameTitle
Patrick Kron Chairman & Chief Executive Officer
Olivier Pirotte Chief Financial Officer
Paul Guy B. Desmarais Vice Chairman
Aldo Cardoso Independent Director
Ian Gallienne Non-Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
IMERYS-9.81%3 315
TIANQI LITHIUM CORP--.--%4 305
GRAFTECH INTERNATIONAL LTD.20.89%4 004
JINDUICHENG MOLYBDENUM CO LTD14.36%3 117
GEM CO LTD--.--%2 511
AURUBIS7.68%2 311